| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
38,447 | 44,932 | 0 | 0 | 0 |
|
Cost of Revenue
|
-23,404 | -26,916 | 0 | -- | -- |
|
Gross Profit
|
15,043 | 18,016 | 0 | -- | -- |
| Selling, General and Administrative Expenses
|
-25,417 | -27,822 | -19,740 | -52,881 | -86,245 |
|
Research and Development Expenses
|
-77,621 | -61,886 | -41,300 | -111,743 | -157,830 |
| Depreciation, Amortization and Depletion
|
-- | -- | -- | -8,226 | -8,125 |
| Other Income/Expense, Operating
|
9,058 | 2,594 | 625 | 948 | 1,086 |
|
Operating Income/Expenses
|
-93,980 | -87,114 | -60,415 | -163,676 | -251,114 |
|
Total Operating Profit/Loss
|
-78,937 | -69,098 | -60,415 | -163,676 | -251,114 |
| Total Net Finance Income/Expense
|
-5,214 | -6,731 | 1,042 | 3,422 | 3,051 |
| Net Investment Income
|
-1,941 | -2,197 | -32,239 | 567 | 17,246 |
| Irregular Income/Expenses
|
-17,746 | -17,746 | -1,474 | -29,091 | -1 |
|
Other Income/Expense, Non-Operating
|
1,880 | -231 | -238 | -42 | -50 |
|
Non-Operating Income/Expenses, Total
|
-23,021 | -26,905 | -32,909 | -25,144 | 20,246 |
|
Pretax Income
|
-101,958 | -96,003 | -93,324 | -188,820 | -230,868 |
|
Provision for Income Tax
|
27,024 | 27,569 | 0 | 0 | 0 |
|
Net Income from Continuing Operations
|
-74,934 | -68,434 | -93,324 | -188,820 | -230,868 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-74,934 | -68,434 | -93,324 | -188,820 | -230,868 |
|
Non-Controlling/Minority Interests
|
-566 | -1,619 | 5,380 | 12,927 | 26,632 |
|
Net Income after Non-Controlling/Minority Interests
|
-75,500 | -70,053 | -87,944 | -175,893 | -204,236 |
|
Net Income Available to Common Stockholders
|
-75,500 | -70,053 | -87,944 | -175,893 | -204,236 |
|
Diluted Net Income Available to Common Stockholders
|
-75,500 | -70,053 | -87,944 | -175,893 | -204,236 |
| Basic EPS
|
-0.29 | -0.29 | -0.36 | -0.72 | -0.84 |
| Diluted EPS
|
-0.29 | -0.29 | -0.36 | -0.72 | -0.84 |
|
Basic Weighted Average Shares Outstanding
|
243,417 | 243,417 | 243,417 | 243,417 | 243,745 |
|
Diluted Weighted Average Shares Outstanding
|
243,417 | 243,417 | 243,417 | 243,417 | 243,745 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-93,557 | -89,272 | -94,366 | -192,242 | -233,919 |
|
EBITDA
|
-72,880 | -71,094 | -86,192 | -170,887 | -213,062 |
|
Normalized EBITDA
|
-54,729 | -52,618 | -53,465 | -96,838 | -91,256 |
12/31/2022 - 12/23/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade